跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
AURO-TOFACITINIB
Authorized
STANDARD
AURO-TOFACITINIB
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e06d29d411c4c2c7
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
e06d29d411c4c2c7
Drug Approval Canada Name
AURO-TOFACITINIB
Product Name
AURO-TOFACITINIB
Status
Marketed
Status Date
2022-11-28
Original Market Date
2022-11-28
Din
02530015
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:24.12.92
Atc Original
L04AF01 TOFACITINIB
Atc Name
l 04 af 01
Aig Number
0155550003
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
TOFACITINIB (TOFACITINIB CITRATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e06d29d411c4c2c7
Type
Standard
Back to Health Canada Approvals
AURO-TOFACITINIB - Health Canada Drug Approval Details